European Healthtech startup funding raised during H1 2015.
In H1 2015, 81 European Healthtech companies raised a combined €490M across 87 funding rounds, up 26.0% versus H1 2014. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 23 Aug 2026.
9 exits · €295M disclosed.
| Dezima Pharma | Acquisition | Mar 2015 | €273M |
| AMO Pharma | Buyout | Jun 2015 | €23M |
| €31M |
| Veryan Medical | Series B | Jan 2015 | €23M |
| Advanced Accelerator Applications | Growth/Late | Jun 2015 | €23M |
| Orphazyme | Series B | Jan 2015 | €20M |
| GenKyoTex | Series D+ | Jan 2015 | €17M |
| EarlySense | Series D+ | Jan 2015 | €16M |
| Allecra Therapeutics | Series A | Apr 2015 | €15M |
| BONESUPPORT | Growth/Late | Apr 2015 | €13M |
| Onbone | Early VC | Apr 2015 | €10M |
| Vittamed | Other | Apr 2015 | €9.3M |
| docplanner | Series B | May 2015 | €8.9M |
| TalkSpace | Series A | May 2015 | €8.5M |
